Phase 1 corresponds to a high level of activity in the primary afferent as a result of C-fiber activation due to peripheral stimulation, whereas phase 2 results from a continuous low-level small afferent input, together with a facilitated state of spinal processing [21]
Curr Pharm Biotechnol
4 and Supplementary materials Tables 24)
It also supports detox pathways, especially when paired with treatments like IV therapy and peptides
Results are inconsistent and slow 1
Hormone Replacement Therapy Consult $450 BPC-157 can be administered in several ways: Research and anecdotal reports suggest BPC-157 may: Although generally considered safe in research, reported side effects may include nausea, headaches, digestive issues, fatigue, appetite changes, fluid retention, dizziness, and fluctuations in blood sugar levels